New Depression Treatment Trial Begins with First Patient Dosed
Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD), […]
Biotech Industry Faces Uncertain Times, But Hope Lies in Upcoming Drug Trials
The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones